Metro Biotech Private Limited
About Metro Biotech Private Limited
Data last updated:
Metro Biotech Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the agricultural support and advisory segment of the agriculture sector. It was incorporated on 02 February 2001 and has been in existence for over 25 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24124MH2001PTC130696.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors including Sanjay Chandulal Kalantri and Harinarayan Bhikchand Chichani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Aurangabad, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.8 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹2.1 Lakh (net margin 43.7%) and EBITDA of ₹2.1 Lakh (EBITDA margin 43.7%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 28% over five years.
As per MCA filings, the company has satisfied charges of ₹2 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Metro Biotech Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressAwing 1 Stfloor Bharatbazarcomplex Apicompound Plotno.P – 72/6 7&8 Midcc, Hikalthana, Aurangabad, Maharashtra, India – 431007
- IndustryAgriculture, Agri Support Services
To see the full contact details of Metro Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Metro Biotech Private Limited
FY 2025 filings availableMetro Biotech Private Limited reported revenue of ₹4.8 Lakh (up 5% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 5% growth in the latest year. EBITDA fell 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.1 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.1 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 43.7% | ||||
| Net Profit Margin | 43.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Metro Biotech Private Limited, buy the company report.
Board of directors of Metro Biotech Private Limited
Metro Biotech has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Chandulal Kalantri Also directs: Horus Pharma India Limited, Prakalp Private Limited, Future Auto Private Limited and 5 more | Director | 20 Jun 2006 | 20 Years 4 Months | Current |
| Harinarayan Bhikchand Chichani Also directs: Horus Pharma India Limited, Prakalp Private Limited, Future Auto Private Limited and 5 more | Director | 20 Jun 2006 | 20 Years 4 Months | Current |
| Gaurav Chandrakant Malpani Also directs: Wire Craft Solution Technology Private Limited, A to Z Commercial Trades Private Limited, Shubhakamna Infrabuild LLP and 5 more | Director | 07 Aug 2009 | 17 Years 2 Months | Current |
| Chandrakant Hanumandas Malpani Also directs: Century Logistic Infrastructures LLP, Suraaj Agrofarms LLP, Horus Pharma India Limited and 5 more | Director | 20 Jun 2006 | 20 Years 4 Months | Current |
Peer comparison
Metro Biotech Private Limited is compared with the 3 companies closest to it by revenue in the Agriculture industry (Farm Produce), with the same principal business activity (support activities to agriculture and other activities including hunting), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Chirackal Plantations Private Limited | ₹4.84 Lakh (FY 2025) | 161.0% | Ernakulam, Kerala, India | |||
| Agro Growers Private Limited | ₹4.8 Lakh (FY 2025) | Bangalore, Karnataka, India | ||||
| Janardhan Herbs and Research Centre Private Limited | ₹4.8 Lakh (FY 2025) | -94.0% | Uttarakhand, India | |||
| Metro Biotech Private Limitedthis company | ₹4.8 Lakh (FY 2025) | ₹2.1 Lakh | 43.7% | 5.0% | Aurangabad, Maharashtra, India |
To see the full peer comparison of Metro Biotech Private Limited, buy the company report.
Auditor
Metro Biotech Private Limited is audited by CHARKHA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CHARKHA & ASSOCIATES | FY 2021 | 116614W |
Shareholding
The shareholding of Metro Biotech Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Metro Biotech Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jun 2006 | 10008757 | The Akola Urban Co-Op. Bank Limtied | ₹2 Cr | Satisfied |
To see the full charge records of Metro Biotech Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Metro Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Metro Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Metro Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Metro Biotech Private Limited has 6 board changes on record since 2006: 4 appointments and 2 cessations. The latest: Gaurav Chandrakant Malpani was appointed as Director on 07 Aug 2009.
Frequently asked questions
Metro Biotech is an active private limited company based in Aurangabad, Maharashtra, India. The company works in agri support services, within the agriculture industry. It was incorporated on 02 February 2001 (25+ years old) and is registered under CIN U24124MH2001PTC130696.
Metro Biotech has 4 current directors:
- Sanjay Chandulal Kalantri - Director
- Harinarayan Bhikchand Chichani - Director
- Gaurav Chandrakant Malpani - Director
- Chandrakant Hanumandas Malpani - Director
The latest financial statements of Metro Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Metro Biotech is U24124MH2001PTC130696. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Metro Biotech was incorporated on 02 February 2001, making it 25+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Metro Biotech by revenue are Chirackal Plantations Private Limited, Agro Growers Private Limited, Janardhan Herbs and Research Centre Private Limited, all in the Agriculture industry (Farm Produce), with the same principal business activity (support activities to agriculture and other activities including hunting).
Gaurav Chandrakant Malpani was appointed as Director on 07 Aug 2009. Nakul Satyanarayan Chandak ceased to be Director on 07 Aug 2009. Pramila Bhagirath Chandak ceased to be Director on 07 Aug 2009. Metro Biotech has 6 board changes on record in total.
The registered office of Metro Biotech is at Awing 1 Stfloor Bharatbazarcomplex Apicompound Plotno.P – 726 7&8 Midcc, Hikalthana, Aurangabad, Maharashtra, India – 431007.
Metro Biotech operates in the agriculture industry, in the agri support services segment.
Metro Biotech has no open charges and satisfied charges of ₹2 Cr as per latest MCA filings.
The compliance status of Metro Biotech is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.